News

Scandinavian Tobacco Group A/S Announces EUR 300M Bond Issue

Scandinavian Tobacco Group A/S Announces EUR 300M Bond Issue

Scandinavian Tobacco Group A/S Announces EUR 300 Million Notes

Scandinavian Tobacco Group A/S is excited to share that it has successfully priced a new issuance of senior unsecured notes amounting to EUR 300 million. These notes feature a coupon rate of 4.875% and are scheduled to mature in September 2029.

Notes Issuance Details

The new notes are anticipated to be issued on 12 September and will be available for trading on the regulated market of Euronext Dublin. This strategic initiative enables the company to raise capital, which will be directed towards a variety of general corporate purposes, including the refinancing of existing debt obligations.

Credit Rating Information

To support this issuance, Moody’s Investor Services has assigned a Baa3 rating to the bonds, which is consistent with the current rating for Scandinavian Tobacco Group A/S. This positive rating underscores the company’s stable economic position and its dedication to maintaining robust financial practices.

Joint Bookrunners Involved

A reputable group of banks served as joint bookrunners for this transaction, including Citigroup Global Markets Europe AG, Danske Bank A/S, Jyske Bank A/S, and Nordea Bank Abp. Each of these institutions played a vital role in executing this bond offering, reflecting their confidence in the company’s growth potential.

Looking Ahead

This bond issuance represents an important milestone for Scandinavian Tobacco Group A/S as it seeks to improve its financial flexibility. By refinancing its existing debts, the company aims to enhance its capital structure, which will facilitate greater operational efficiency and better position itself for future growth in the market.

Contact Details

For any further inquiries, please contact Torben Sand, the Director of IR & Communication, at +45 5084 7222 or via email at torben.sand@st-group.com.

Frequently Asked Questions

What is Scandinavian Tobacco Group A/S?

Scandinavian Tobacco Group A/S is a prominent international tobacco company that specializes in the production of cigars and pipe tobacco.

What are the terms of the newly issued notes?

The notes have a total principal amount of EUR 300 million, a coupon rate of 4.875%, and are set to mature in September 2029.

Where will the bond be listed?

The bond will be listed on the regulated market of Euronext Dublin.

Why did Scandinavian Tobacco Group A/S issue these notes?

The funds raised from this issuance will be allocated for various corporate purposes, particularly to refinance existing debt.

Who were involved in the issuance process?

Citigroup Global Markets Europe AG, Danske Bank A/S, Jyske Bank A/S, and Nordea Bank Abp acted as joint bookrunners for the transaction.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kenox Pharmaceuticals Revolutionizes Drug Development Landscape

Updated Category News Views 272

Revolutionizing Drug Development Approaches Kenox Pharmaceuticals Inc, a leading name in the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs), has recently announced an exciting extension of its capabilities. The introduction of small scale non-sterile GMP capabilities marks a significant enhancement to its already comprehensive drug development...

Continue Reading
Exciting Listing of AI-themed ATC Coin on CoinW Exchange

Updated Category News Views 211

Exciting Listing of AI-themed ATC Coin on CoinW Exchange CoinW, recognized as a trailblazer in the realm of cryptocurrency trading platforms, is thrilled to announce the listing of ATC, an innovative meme coin designed around artificial intelligence. ATC will be available for trading in both AI, MEME, and SOL Zones. To celebrate this momentous occasion, which marks an...

Continue Reading
Webstar Technology Group’s Innovative Blockchain Venture

Updated Category News Views 370

Revolutionizing Real Estate with Blockchain Tokenization Webstar Technology Group (OTCMKTS: WBSR) is stepping into the future with a bold initiative that harnesses the power of blockchain technology for real estate ventures. This forward-thinking approach not only highlights the company's commitment to innovation but also positions it as a leader in the rapidly evolving...

Continue Reading
Class Action Lawsuits Update: ATYR, MLTX, BAX, JHX

Updated Category News Views 167

Overview of Recent Class Action Lawsuits Several publicly traded companies are facing legal challenges with class action lawsuits initiated on behalf of their shareholders. It's crucial for investors in these companies to be aware of their rights and the deadlines for potential legal actions. This article discusses the companies involved and provides essential information...

Continue Reading
Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Updated Category News Views 164

Partnership Expansion Between Biodesix and Bio-Rad Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications....

Continue Reading